Centene warns of hit to fast-growing Medicare Advantage business next year
Reuters
Published Feb 07, 2023 06:13AM ET
Updated Feb 07, 2023 05:18PM ET
By Raghav Mahobe and Nandhini Srinivasan
(Reuters) -Centene Corp on Tuesday said profit at its fast-growing Medicare Advantage (MA) business will take a beating in 2024 due to a sharp cut in its rating by a U.S. federal agency and likely lower-than-expected government payouts to health insurers.
The gloomy outlook for MA, one of the fastest growing businesses for health insurers, clouded Centene (NYSE:CNC)'s fourth-quarter profit beat and sent the company's shares down nearly 2% in early trade.
Health insurers who operate MA plans have come under pressure after the U.S. Centers for Medicare and Medicaid Services (CMS) recently proposed new rules for an audit program to avoid overpaying the companies.
The agency proposed a 2.3% drop in reimbursement rates last week, compared with a 5% growth in 2023. The final rates are expected by April 3.
Bigger rival Cigna Corp (NYSE:CI) has also said if the rate change goes through, it "will create some revenue dislocation".
Centene does not expect its MA business to grow next year and it will likely "shrink a little", Chief Financial Officer Andrew Asher said in a post-earnings conference call.
Asher said the company expects negative profit margins in the business in 2024 temporarily, after CMS cut star rating for Centene's MA plans in October.
MA plans are government-supported insurance plans that private companies offer people over 65 years of age.
In the fourth quarter, Centene reported an adjusted profit of 86 cents per share, beating Wall Street estimates by a cent.
The company said its quarterly health benefits ratio, which measures medical costs in relation to premiums collected, stood at 88.7%, better than estimates of 88.8%, according to six analysts polled by Refinitiv.
Revenue from Centene's Medicare health insurance business rose about 24% to $5.45 billion from a year earlier.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.